Halozyme Therapeutics (HALO)

Halozyme (HALO) Financial Statements


Halozyme Financial Overview

Halozyme's market cap is currently ―. The company's EPS TTM is $1.443; its P/E ratio is 23.89; Halozyme is scheduled to report earnings on May 9, 2023, and the estimated EPS forecast is $0.38. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 181.50M$ 208.98M$ 152.37M$ 117.28M$ 102.00M
Gross Profit$ 139.38M$ 161.66M$ 118.42M$ 101.36M$ 80.42M
EBIT$ 75.36M$ 81.22M$ 33.12M$ 76.17M$ 56.87M
EBITDA$ 82.47M$ 110.42M$ 45.66M$ 76.95M$ 57.64M
Net Income Common Stockholders$ 57.70M$ 61.63M$ 22.68M$ 60.11M$ 66.77M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 362.79M$ 265.58M$ 209.36M$ 786.14M$ 740.92M
Total Assets$ 1.84B$ 1.86B$ 1.78B$ 1.16B$ 1.10B
Total Debt$ 1.51B$ 1.50B$ 1.25B$ 877.64M$ 876.67M
Net Debt$ 1.14B$ 1.24B$ 1.04B$ 91.50M$ 135.75M
Total Liabilities$ 1.67B$ 1.77B$ 1.49B$ 901.99M$ 907.48M
Stockholders Equity$ 169.80M$ 96.99M$ 293.17M$ 260.26M$ 196.95M
Cash Flow-
Free Cash Flow$ 80.11M$ 68.63M$ 39.26M$ 47.31M$ 82.36M
Operating Cash Flow$ 82.45M$ 69.64M$ 40.23M$ 47.80M$ 82.52M
Investing Cash Flow$ -1.75M$ -1.01M$ -434.95M$ -49.30M$ -299.47M
Financing Cash Flow$ 6.33M$ -12.40M$ 367.82M$ 624.00K$ -156.01M
Currency in USD

Halozyme Earnings and Revenue History

Halozyme Debt to Assets

Halozyme Cash Flow

Halozyme Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis